Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003
- PMID: 17498853
- DOI: 10.1016/j.vaccine.2007.04.020
Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003
Abstract
The purpose of this study was to investigate mumps vaccine failures (VF) in a highly vaccinated population of Minsk, Belarus, and to investigate a possible role for virus strain-specific immunity. During our 3-year study period, 22 adults were admitted to the Infectious Diseases Hospital in Minsk with a diagnosis of mumps. A genotype H1 mumps virus (MuV) strain was identified in all patients. Of 15 patients from whom the paired sera were collected, 9 were confirmed to have been previously vaccinated. Serological examinations indicated primary VF in seven of these cases and secondary VF in two. Despite almost all vaccinated patients possessing MuV specific IgG, few possessed neutralizing antibody to the vaccine strain and titers were nominal. Importantly, none of the sera were able to neutralize a genotype H MuV strain. Our results demonstrate the importance of assaying for neutralizing antibody and support the assertion that antigenic differences between wild type and vaccine MuV strains may play a role in cases of breakthrough infection in vaccinees.
Similar articles
-
Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.Clin Microbiol Infect. 2007 Jul;13(7):670-6. doi: 10.1111/j.1469-0691.2007.01727.x. Epub 2007 May 2. Clin Microbiol Infect. 2007. PMID: 17484765
-
Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains.Vaccine. 2006 Mar 24;24(14):2662-8. doi: 10.1016/j.vaccine.2005.10.050. Epub 2005 Nov 8. Vaccine. 2006. PMID: 16309801
-
Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.J Infect Dis. 2008 Aug 15;198(4):508-15. doi: 10.1086/590115. J Infect Dis. 2008. PMID: 18558869
-
The molecular epidemiology of mumps virus.Infect Genet Evol. 2004 Sep;4(3):215-9. doi: 10.1016/j.meegid.2004.02.003. Infect Genet Evol. 2004. PMID: 15450201 Review.
-
[Diagnostic tests: Mumps virus].Nihon Rinsho. 2005 Jul;63 Suppl 7:352-5. Nihon Rinsho. 2005. PMID: 16111272 Review. Japanese. No abstract available.
Cited by
-
Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?Front Immunol. 2020 Sep 18;11:2089. doi: 10.3389/fimmu.2020.02089. eCollection 2020. Front Immunol. 2020. PMID: 33072071 Free PMC article. Review.
-
Immune responses to mumps vaccine in adults who were vaccinated in childhood.J Infect Dis. 2008 Jun 15;197(12):1669-75. doi: 10.1086/588195. J Infect Dis. 2008. PMID: 18419345 Free PMC article.
-
Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection.mSphere. 2018 Sep 12;3(5):e00320-18. doi: 10.1128/mSphere.00320-18. mSphere. 2018. PMID: 30209129 Free PMC article.
-
Molecular characteristics of mumps viruses isolated in Taiwan from 2006 to 2016.Heliyon. 2018 Feb 8;4(2):e00518. doi: 10.1016/j.heliyon.2018.e00518. eCollection 2018 Feb. Heliyon. 2018. PMID: 29560442 Free PMC article.
-
Knowledge gaps persist and hinder progress in eliminating mumps.Vaccine. 2018 Jun 18;36(26):3721-3726. doi: 10.1016/j.vaccine.2018.05.067. Epub 2018 May 18. Vaccine. 2018. PMID: 29784466 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical